Literature DB >> 590603

Once daily administration of pindolol in the treatment of hypertension.

R C Dhatariya, A J Blowers.   

Abstract

An open study was carried out in general practice on patients with mild to moderate essential hypertension to assess the effectiveness of treatment with pindolol on a single daily dose regimen. In twenty-two previously untreated cases given a single daily dosage of pindolol (mean 13-0 mg, range 5 mg- 30 mg), adequate blood pressure control was achieved within five weeks and maintained in the nineteen patients examined at Week 25. Of eleven previously treated patients whose blood pressure was adequately controlled by divided daily doses of pindolol, a change-over to a single daily dosage of pindolol (mean 13-2 mg, range 10 mg-20 mg) did not result in any loss of control over a twenty-five week study period. Few side-effects were reported, and only one patient was withdrawn from the study.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590603     DOI: 10.1177/030006057300100215

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  1 in total

1.  The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.

Authors:  R C Dhatariya; A J Blowers
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.